AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+13.45%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$780M
AUM Growth
+$171M
(+28%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
17.53%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81
Top Buys
| 1 |
Merck
MRK
|
$9.17M |
| 2 |
Broadcom
AVGO
|
$7.81M |
| 3 |
TSMC
TSM
|
$6.87M |
| 4 |
MDC
M.D.C. Holdings, Inc.
MDC
|
$6.84M |
| 5 |
Open Text
OTEX
|
$5.7M |
Top Sells
| 1 |
Fox Class A
FOXA
|
$9.87M |
| 2 |
Diamondback Energy
FANG
|
$9.52M |
| 3 |
Home Depot
HD
|
$7.42M |
| 4 |
Accenture
ACN
|
$7.15M |
| 5 |
MetLife
MET
|
$6.8M |
Sector Composition
| 1 | Technology | 21.2% |
| 2 | Consumer Discretionary | 17.87% |
| 3 | Industrials | 15.32% |
| 4 | Healthcare | 12.76% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $405K | 0.05% |
8,065
| – | – |
|
327
Rio Tinto
RIO
$104B
| $402K | 0.05% |
6,293
+1,474
| +31% | +$94.1K |
|
328
D.R. Horton
DHI
$54.1B
| $401K | 0.05% |
3,294
+1,240
| +60% | +$151K |
|
329
Olympic Steel
ZEUS
$379M
| $401K | 0.05% |
8,179
+1,042
| +15% | +$51.1K |
|
330
Brilliant Earth
BRLT
$41.9M
| $391K | 0.05% |
100,782
-64,224
| -39% | -$249K |
|
331
James Hardie Industries plc
JHX
$11.7B
| $389K | 0.05% |
+14,473
| New | +$389K |
|
332
Unilever
UL
$158B
| $389K | 0.05% |
7,460
+1,680
| +29% | +$87.6K |
|
333
DXP Enterprises
DXPE
$1.96B
| $387K | 0.05% |
+10,640
| New | +$387K |
|
334
Lennar Class A
LEN
$36.7B
| $387K | 0.05% |
+3,190
| New | +$387K |
|
335
Blue Bird Corp
BLBD
$1.87B
| $387K | 0.05% |
+17,202
| New | +$387K |
|
336
Spotify
SPOT
$146B
| $386K | 0.05% |
2,406
-396
| -14% | -$63.6K |
|
337
Comcast
CMCSA
$125B
| $386K | 0.05% |
+9,287
| New | +$386K |
|
338
GSK
GSK
$81.2B
| $385K | 0.05% |
10,815
+2,418
| +29% | +$86.2K |
|
339
Vertex Pharmaceuticals
VRTX
$101B
| $381K | 0.05% |
+1,084
| New | +$381K |
|
340
Darden Restaurants
DRI
$24.5B
| $381K | 0.05% |
2,279
+602
| +36% | +$101K |
|
341
Gilead Sciences
GILD
$143B
| $380K | 0.05% |
+4,933
| New | +$380K |
|
342
Eaton
ETN
$136B
| $378K | 0.05% |
+1,879
| New | +$378K |
|
343
HCA Healthcare
HCA
$98.3B
| $377K | 0.05% |
+1,241
| New | +$377K |
|
344
KBR
KBR
$6.39B
| $376K | 0.05% |
5,783
-1,471
| -20% | -$95.7K |
|
345
Patrick Industries
PATK
$3.77B
| $376K | 0.05% |
7,044
+292
| +4% | +$15.6K |
|
346
Spire
SR
$4.45B
| $372K | 0.05% |
5,858
+239
| +4% | +$15.2K |
|
|
BELFB
347
Bel Fuse Class B
BELFB
$1.81B
| $371K | 0.05% |
+6,461
| New | +$371K |
|
348
Fiserv
FI
$73.3B
| $368K | 0.05% |
+2,918
| New | +$368K |
|
349
Aon
AON
$79.7B
| $368K | 0.05% |
+1,065
| New | +$368K |
|
350
Boston Scientific
BSX
$159B
| $365K | 0.05% |
+6,756
| New | +$365K |
|